2280:TADAWULAlmarai Company Analysis
Data as of 2026-05-21 - not real-time
SAR 44.74
Latest Price
5/10Risk
Risk Level: Medium
Executive Summary
Almarai’s shares are trading below the short‑term and mid‑term moving averages and sit near a key support level, suggesting short‑term downside pressure. However, the MACD histogram is positive and the RSI reflects moderate bullish momentum, while volume has been on an upward trend, indicating that buying interest may be building. The stock’s beta is near zero, which limits market‑wide volatility, but its 30‑day price swings remain relatively high and the fear/greed index is in the extreme greed zone, pointing to a potentially overheated market sentiment.
Fundamentally, the company delivers steady revenue growth and respectable margins, maintains a dividend yield above two percent with a payout ratio around forty percent, and shows a solid analyst consensus of “buy.” The discounted cash‑flow model places fair value well above the current price, implying a sizable upside, while the debt‑to‑equity ratio is moderate and cash flow from operations remains healthy, supporting the view that the dividend is sustainable and the stock is undervalued.
Fundamentally, the company delivers steady revenue growth and respectable margins, maintains a dividend yield above two percent with a payout ratio around forty percent, and shows a solid analyst consensus of “buy.” The discounted cash‑flow model places fair value well above the current price, implying a sizable upside, while the debt‑to‑equity ratio is moderate and cash flow from operations remains healthy, supporting the view that the dividend is sustainable and the stock is undervalued.
Market Outlook
Short Term
< 1 yearPositive
Model confidence: 7/10
Key Factors
- Price near support with bullish MACD crossover
- Rising volume indicating accumulating interest
- Low beta limiting market‑wide shocks
Medium Term
1–3 yearsPositive
Model confidence: 8/10
Key Factors
- DCF valuation shows significant upside
- Attractive dividend yield with reasonable payout
- Stable earnings growth and solid margins
Long Term
> 3 yearsPositive
Model confidence: 8/10
Key Factors
- Defensive consumer sector positioning
- Sustainable dividend supported by operating cash flow
- Undervalued relative to intrinsic fair value
Key Metrics & Analysis
Financial Health
Revenue Growth6.80%
Profit Margin10.94%
P/E Ratio18.2
ROE12.04%
ROA4.84%
Debt/Equity66.95
P/B Ratio2.1
Op. Cash FlowSAR5.6B
Free Cash FlowSAR-1251993472
Technical Analysis
TrendBearish
RSI60.6
SupportSAR 40.22
ResistanceSAR 45.22
MA 20SAR 42.40
MA 50SAR 42.93
MA 200SAR 45.02
MACDBullish
VolumeIncreasing
Fear & Greed Index90.29
Valuation
Fair ValueSAR 55.57
Target PriceSAR 56.81
Upside/Downside26.98%
GradeUndervalued
TypeBlend
Dividend Yield2.57%
Risk Assessment
Beta0.00
Volatility34.87%
Sector RiskLow
Reg. RiskMedium
Geo RiskMedium
Currency RiskLow
Liquidity RiskLow
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.